Sign inJoin waitlistJoin the waitlist

JS

Jennifer Segar

Physician · Texas Oncology

Credentials: · · · · · ·

History

Texas Oncology
2025–Present

Hematology and Medical Oncology
University of Arizona
2013–2016
Internal Medicine
UA College of Medicine Internal Medicine Residency Program
2012–2013
Ross University School of Medicine
2008–2012
University of Southern California
2005–2008

Research

Individualised neoantigen therapy mRNA-4157 (V940) plus pembrolizumab versus pembrolizumab monotherapy in resected melanoma (KEYNOTE-942): a randomised, phase 2b study
The Lancet · 2024 · 686 citations
Comparative Effectiveness of Newer Tyrosine Kinase Inhibitors Versus Imatinib in the First-Line Treatment of Chronic-Phase Chronic Myeloid Leukemia Across Risk Groups: A Systematic…
Systematic review or meta-analysis · Clinical Lymphoma · 2016 · 30 citations
Azenosertib Is a Potent and Selective WEE1 Kinase Inhibitor with Broad Antitumor Activity Across a Range of Solid Tumors
Molecular Cancer Therapeutics · 2025 · 12 citations

Pavani Dome
8 papers
Kiah Farr
3 papers · 3 as a resident
Mihra Taljanovic
3 papers
Alison Stopeck
2 papers
Sao Jiralerspong
2 papers
Alejandro Boiles
1 paper
Andrew Pecora
1 paper
AH
Anne Hatch
1 paper
Brentin Roller
1 paper · 1 as a fellow
Charles Cowey
1 paper
Dany Tager
1 paper · 1 as a resident
Darien Reed-Perino
1 paper · 1 as a resident